Real-world progression in the survival of de novo Metastatic prostate cancer over the past decade

CONCLUSION: The survival of mPCa have significantly improved over the past decade, although the progress is slower in elderly patients. Investigating the underlying reasons for survival differences among various patient profiles can further refine mPCa treatment strategies.PMID:38097476 | DOI:10.1016/j.urolonc.2023.11.021

Source: Urologic Oncology - December 14, 2023 Category: Urology & Nephrology Authors: Xiaoxiao Guo Haoran Xia Fengbo Zhang Gangyue Hao Source Type: research